Ligand validation:3HKP

6PL: (4S,7R)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE

6PL is a Ligand Of Interest in 3HKP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HKP_6PL_A_283	15%	39%	0.202	0.798	1.12	1.24	2	3	2	0	79%	0.7885
3I4Y_6PL_A_282	38%	40%	0.146	0.884	1.08	1.27	2	4	0	0	79%	0.7885
3I4V_6PL_A_283	35%	41%	0.143	0.868	1.05	1.23	2	4	0	0	79%	0.7885
3I51_6PL_A_282	24%	38%	0.158	0.823	1.03	1.38	2	6	1	0	79%	0.7885
3HJQ_6PL_A_282	19%	40%	0.185	0.813	1.13	1.22	2	3	2	0	79%	0.7885
3HJ8_6PL_A_283	18%	41%	0.198	0.822	1.1	1.2	2	4	1	0	79%	0.7885
3B7Z_6PL_A_312	41%	56%	0.159	0.896	0.64	1.05	-	4	7	0	87%	0.3462
3B7Q_6PL_A_314	38%	58%	0.213	0.915	0.6	1.02	-	4	9	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.